cover
Contact Name
Adam Mudinillah
Contact Email
adammudinillah@staialhikmahpariangan.ac.id
Phone
+6285379388533
Journal Mail Official
adammudinillah@staialhikmahpariangan.ac.id
Editorial Address
Jorong Kubang Kaciak Dusun Kubang Kaciak, Kelurahan Balai Tangah, Kecamatan Lintau Buo Utara, Kabupaten Tanah Datar, Provinsi Sumatera Barat, Kodepos 27293.
Location
Kab. tanah datar,
Sumatera barat
INDONESIA
Journal of Biomedical and Techno Nanomaterials
ISSN : 30481120     EISSN : 30481155     DOI : 10.70177/jbtn
Core Subject : Science,
Journal of Biomedical and Techno Nanomaterials is an international forum for the publication of peer-reviewed integrative review articles, special thematic issues, reflections or comments on previous research or new research directions, interviews, replications, and intervention articles - all pertaining to the research fields of medicine, pharmaceuticals, biomaterials, biotechnology, diagnosis and prevention of diseases, biomedical devices, bioinformatics, and all other related fields of biomedical and life sciences. All publications provide breadth of coverage appropriate to a wide readership in Biomedical and Techno Nanomaterials research depth to inform specialists in that area. We feel that the rapidly growing Journal of Biomedical and Techno Nanomaterials community is looking for a journal with this profile that we can achieve together. Submitted papers must be written in English for initial review stage by editors and further review process by minimum two international reviewers.
Articles 55 Documents
PERSONALIZED NANOMEDICINE APPROACHES ENABLED BY BIOINFORMATICS AND MACHINE LEARNING Li, Zhang; Mei, Chen; Jing, Wang
Journal of Biomedical and Techno Nanomaterials Vol. 3 No. 1 (2026)
Publisher : Yayasan Adra Karima Hubbi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70177/jbtn.v3i1.3559

Abstract

Personalized nanomedicine has emerged as a promising approach to tailor treatments to individual patients, enhancing therapeutic efficacy while minimizing side effects. The integration of bioinformatics and machine learning (ML) has the potential to revolutionize this field by enabling more precise and efficient drug delivery systems, biomarker identification, and therapeutic strategies. However, the full potential of these technologies in personalized nanomedicine remains underexplored. This study aims to explore how bioinformatics and machine learning can enable personalized nanomedicine approaches, particularly in the areas of drug delivery optimization, patient-specific treatment planning, and biomarker discovery. The research investigates the application of these technologies in identifying individualized treatment strategies and improving patient outcomes. A systematic review of the current literature on bioinformatics, machine learning, and personalized nanomedicine was conducted. Case studies and experimental research using these technologies were analyzed to identify trends, applications, and challenges. Machine learning models were applied to bioinformatics datasets to predict drug responses and optimize nanomedicine formulations. The study found that bioinformatics and ML significantly enhance the accuracy of drug efficacy predictions, biomarker identification, and the design of personalized nanomedicine treatments. Furthermore, these technologies have improved patient-specific therapy optimization in clinical trials. The combination of bioinformatics and machine learning holds great promise for advancing personalized nanomedicine, offering tailored therapeutic solutions that improve patient outcomes and treatment efficiency.
BIOMIMETIC NANOMATERIALS FOR ADVANCED BIOMEDICAL IMPLANTATION Thai, Aom; Chai, Nong; Chai, Som
Journal of Biomedical and Techno Nanomaterials Vol. 3 No. 1 (2026)
Publisher : Yayasan Adra Karima Hubbi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70177/jbtn.v3i1.3560

Abstract

Biomimetic nanomaterials, inspired by natural systems, have gained significant attention in the field of biomedical implants due to their ability to mimic the properties of biological tissues. These materials offer advantages such as enhanced biocompatibility, improved mechanical properties, and the potential to promote tissue regeneration. The integration of biomimetic nanomaterials into biomedical implants could revolutionize the field of medical devices by improving their functionality and longevity. This study aims to explore the development and application of biomimetic nanomaterials for advanced biomedical implantation. The research focuses on evaluating their mechanical, biological, and functional properties to determine their suitability for use in medical implants. A systematic review of the latest studies on biomimetic nanomaterials for biomedical applications was conducted. Materials such as hydroxyapatite, collagen-based nanomaterials, and nanostructured metals were analyzed for their properties, performance, and potential for use in various implant types. In vitro and in vivo studies were included to assess biocompatibility and efficacy. The findings demonstrate that biomimetic nanomaterials significantly improve the performance of biomedical implants. These materials exhibit superior biocompatibility, enhanced cell adhesion, and promote better tissue integration compared to conventional materials. Biomimetic nanomaterials offer promising solutions for advanced biomedical implants. Their ability to closely mimic biological tissue properties enhances implant functionality and integration, leading to improved patient outcomes.
PRECLINICAL EVALUATION OF NANOMATERIAL-BASED THERAPEUTICS FOR TRANSLATIONAL MEDICINE Teo, Ryan; Tan, Ethan; Lee, Ava
Journal of Biomedical and Techno Nanomaterials Vol. 3 No. 1 (2026)
Publisher : Yayasan Adra Karima Hubbi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70177/jbtn.v3i1.3561

Abstract

Nanomaterial-based therapeutics have shown immense promise in translational medicine, offering innovative solutions for targeted drug delivery, cancer therapy, and regenerative medicine. The unique properties of nanomaterials, including their high surface area, biocompatibility, and ability to be engineered for specific functions, make them ideal candidates for improving the precision and efficacy of medical treatments. However, the preclinical evaluation of these nanomaterials is critical to ensuring their safety, efficacy, and clinical applicability. This study aims to evaluate the preclinical performance of nanomaterial-based therapeutics in the context of translational medicine. The research focuses on assessing the pharmacokinetics, biocompatibility, and therapeutic efficacy of nanomaterials in animal models to determine their potential for clinical translation. A series of preclinical tests were conducted using animal models to assess the pharmacokinetics, biodistribution, and toxicity of various nanomaterials. Therapeutic efficacy was evaluated through specific disease models, including cancer and wound healing, using both in vitro and in vivo techniques. The study demonstrated that nanomaterial-based therapeutics exhibited promising pharmacokinetics and high therapeutic efficacy, with minimal toxicity. Nanomaterials showed targeted drug delivery and enhanced therapeutic outcomes in preclinical models, particularly in cancer therapy. Nanomaterial-based therapeutics hold significant potential for advancing translational medicine. Preclinical evaluations confirm their promise for targeted therapy, though further research on long-term safety and clinical translation is needed.
INTEGRATION OF NANOTECHNOLOGY AND REGENERATIVE MEDICINE FOR NEXT-GENERATION HEALTHCARE SOLUTIONS Iqbal, Kiran; Shah, Ahmed; Hussain, Sara
Journal of Biomedical and Techno Nanomaterials Vol. 3 No. 1 (2026)
Publisher : Yayasan Adra Karima Hubbi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70177/jbtn.v3i1.3562

Abstract

Nanotechnology and regenerative medicine are two rapidly evolving fields with the potential to transform healthcare by providing advanced solutions for tissue repair, disease treatment, and personalized medicine. The integration of nanotechnology with regenerative medicine offers the opportunity to enhance the efficacy of stem cell therapies, drug delivery systems, and tissue engineering, enabling more precise and effective treatments. Despite promising results, challenges remain regarding the scalability, biocompatibility, and long-term safety of nanomaterials in clinical applications. This study aims to explore the integration of nanotechnology with regenerative medicine to develop next-generation healthcare solutions. It focuses on evaluating the potential applications, challenges, and future directions of nanomaterial-based therapies in tissue regeneration and disease management. A systematic review of the current literature on nanotechnology and regenerative medicine was conducted. The review included studies on nanomaterials used for tissue engineering, drug delivery, and stem cell therapies. In vitro and in vivo research data were analyzed to assess the effectiveness and biocompatibility of nanomaterial-based approaches. The findings indicate that nanomaterial-based systems significantly improve the performance of regenerative medicine therapies, offering enhanced tissue regeneration, targeted drug delivery, and better integration with biological systems. However, issues like material stability and immune response remain. The integration of nanotechnology and regenerative medicine holds significant potential for advancing healthcare solutions. Addressing the current challenges will be critical for the successful translation of these technologies into clinical practice.
PHARMACEUTICAL NANOTECHNOLOGY FOR IMPROVING BIOAVAILABILITY AND THERAPEUTIC EFFICACY Fatima Ahmed; Ali Omar; Muntasir Muntasir
Journal of Biomedical and Techno Nanomaterials Vol. 3 No. 2 (2026)
Publisher : Yayasan Adra Karima Hubbi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70177/jbtn.v3i2.3211

Abstract

Pharmaceutical nanotechnology has emerged as a promising approach to enhance the bioavailability and therapeutic efficacy of drugs. Many drugs suffer from poor solubility, limited absorption, and rapid metabolism, leading to suboptimal therapeutic outcomes. Nanotechnology-based drug delivery systems offer solutions to these challenges by improving the stability, solubility, and controlled release of pharmaceuticals. This study explores the use of nanotechnology in the design and development of drug delivery systems aimed at enhancing bioavailability and optimizing therapeutic efficacy. The primary objective is to evaluate the effectiveness of various nanocarriers, including liposomes, dendrimers, and polymeric nanoparticles, in improving drug solubility and ensuring targeted delivery. The research employs in vitro and in vivo models to assess drug release profiles, absorption rates, and pharmacokinetic properties. The results demonstrate that nanotechnology-based systems significantly improve drug bioavailability and extend therapeutic efficacy by providing controlled and sustained drug release, reducing side effects, and enhancing cellular uptake. In conclusion, pharmaceutical nanotechnology offers a powerful strategy to overcome the limitations of conventional drug delivery systems, providing a pathway for more effective treatments in various therapeutic areas.